生物信息红外肝病治疗仪期门穴位照射联合鳖甲煎丸治疗代偿期肝硬化临床疗效研究

Abstract
Figure/Table
References (15)
Related Citation (2)

Download: PDF (0 KB) HTML (31 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the clinical effect on bioinformatics infrared liver disease therapeutic instrument(BILT treatment instrument) Qimen acupoint irradiation combined with Biejiajian Pills in the treatment of compensated liver cirrhosis.Methods A total of 60 patients with compensatory cirrhosis treated in the Hepatology Department of Jiujiang Traditional Chinese Medicine Hospital from July 2019 to February 2020 were selected as the research objects,and they were divided into the observation group and the control group according to random number table method, with 30 cases in each group.The observation group was treated with BILT liver disease treatment instrument Qimen acupoint irradiation+Biejiajian Pills, and the control group was treated with Biejiajian Pills orally.The changes in the four fiber items and liver stiffness were compared between the two groups.Results After 2, 4, and 6 weeks of treatment, the levels of laminin (LN), hyaluronidase (HA), type Ⅳcollagen (Ⅳ-C), type Ⅲprocollagen (PC Ⅲ) and liver stiffness in the observation group were lower than those in the control group, the differences were statistically significant (P＜0.05).Conclusion BILT liver disease treatment Qimen acupoint irradiation combined with Biejiajian Pills has a definite effect in the treatment of compensatory liver cirrhosis, which can reduce liver damage, reduce the degree of liver fibrosis, and reduce liver stiffness, and has high clinical promotion value.

Key words： Compensated liver cirrhosis Bioinformatics infrared liver disease treatment instrument Qimen acupoint irradiation Biejiajian Pills Liver hardness

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CHEN Ling
	ZOU Bi-ying
	YIN Dong-lin

Cite this article:

CHEN Ling,ZOU Bi-ying,YIN Dong-lin. Clinical efficacy study on bioinformatics infrared liver disease therapeutic instrument Qimen acupoint irradiation combined with Biejiajian Pills in the treatment of compensated liver cirrhosis[J]. 中国当代医药, 2021, 28(8): 165-167转174.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I8/165

[1]	张自成，梅冬雪，刘斌，等.双环醇联合异甘草酸镁治疗失代偿期肝硬化疗效观察[J].中华实用诊断与治疗杂志，2017，31（1）：76-78.
[2]	路振宇，朱孝轩.宽胸散结和胃通腑法在代偿期肝硬化抗肝纤维化治疗过程中的运用体会[J].河北中医药学报，2017，32（5）：23-24，29.
[3]	杨丽，张艳春，刘晓冉.益气散结方联合恩替卡韦治疗失代偿期乙型肝炎肝硬化患者的临床疗效分析[J].世界中医药，2017，12（3）：543-546.
[4]	卞镝，隋月皎，田辉.伤寒论期门穴应用探究[J].中国针灸，2018，34（4）：387-389.
[5]	中国中西医结合学会消化系统疾病专业委员会.肝硬化中西医结合诊疗共识[J].中国中西医结合消化杂志，2011，19（4）：277-279.
[6]	韦玲，谢会忠，翁敬飚，等.失代偿期肝硬化患者医院感染危险因素及病原学特点探讨[J].中华医院感染学杂志，2017，27（21）：4842-4845.
[7]	杨惠敏，蒋春彦.软肝汤联合阿德福韦酯治疗代偿期乙肝肝硬化42例[J].西部中医药，2017，30（12）：82-84.
[8]	杜宏波，江宇泳，薛亚春，等.96例原发性胆汁性肝硬化患者中医证候调查[J].中医杂志，2017，58（7）：575-578.
[9]	罗伟康，王宪贝，王加锋.浅谈对《金匮要略》鳖甲煎丸方证的理解[J].四川中医，2018，36（4）：25-28.
[10]	薛建华，成扬，陈建杰，等.鳖甲煎丸联合恩替卡韦治疗乙肝肝纤维化临床观察[J].中医药信息，2019，36（2）：57-60.
[11]	陈姼姼，陈晓蓉，徐庆年，等.肝病红外治疗仪联合针灸对肝郁脾虚型肝硬化患者的临床疗效观察[J].世界中医药，2017，12（5）：1138-1140.
[12]	刘雅丽，孟祥林，王恩杰，等.肝硬化腹水患者基于子午流注理论下荷叶封包联合红外线照射治疗的护理[J].护理学杂志，2017，32（23）：39-41.
[13]	余静芳，周晓玲，刘莹，等.基于红外热成像技术探讨从脾阳虚证论治乙型肝炎肝硬化代偿期患者临床疗效[J].辽宁中医药大学学报，2017，19（5）：151-154.
[14]	刘玉宝，梁丽杰，赵立晖，等.生物信息红外肝病治疗仪联合结肠透析对肝硬化肝性脑病患者的疗效观察[J].华南国防医学杂志，2019，33（6）：384-387.
[15]	赵鸿霞，孙运霞，王艳梅，等.生物信息红外肝病治疗仪对慢性乙型肝炎的护理疗效[J].检验医学与临床，2018，15（7）：1020-1022.